Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Allocating to a wide market index fund for retirement aims to spread risk across the market, supporting steady growth while keeping fees reasonable.
28,235 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Keller Williams rolls out a redesigned Command CRM with more than 75 integrations, backed by Stone Point Capital. The...
Investors are weighing three very different tech names as AI upgrades drive Nvidia higher while Qualcomm faces a toug...
EWJ has fallen 9% in the past 30 days while Japan’s economy rides on fragile oil supply lines. The shift tests the op...
Investors often ask where XRP will be in three years. This article examines bear, base, and bull scenarios, plus prac...
The once-rate story has grown into a life-altering reality, as millions of homeowners stay put to protect a valuable ...
Trump argues against rate hikes amid a stubborn inflation backdrop, while Kevin Warsh appears set to influence a hawk...
Gold investors are watching Grok AI forecasts as prices hover near current levels while a structural bull case builds...
SpaceX is expanding beyond rockets with a bold $60B Cursor deal. This strategic shift could redefine how investors va...
Banks and mortgage lenders are accelerating the use of predictive analytics real estate to forecast seller motion and...
Hong Kong lays out plans to connect a new digital bond platform with regional tokenization hubs, moving from pilots t...
Bitcoin, Ethereum and XRP anchor a choppy session as policymakers weigh new rules and traders parse liquidity and ris...